Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Oncology

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2011.958PMID 21373752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged tyrosine kinase activation of insulin receptor by pY27-caveolin-2.

  2010cited by this paper
• A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2

  2010cited by this paper
• Caveolin-2 regulation of STAT3 transcriptional activation in response to insulin.

  2009cited by this paper
• Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells.

  2009cited by this paper
• Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis.

  2009cited by this paper
• Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts

  2009cited by this paper
• Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

  2008cited by this paper
• The multiple faces of caveolae

  2007cited by this paper
• Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth.

  2007cited by this paper
• Caveolin-1 in oncogenic transformation, cancer, and metastasis.

  2005cited by this paper
• Caveolin isoform expression during differentiation of C6 glioma cells

  2005cited by this paper
• Validating Stat3 in cancer therapy

  2005cited by this paper
• Caveolin-2 regulation of the cell cycle in response to insulin in Hirc-B fibroblast cells.

  2005cited by this paper
• A role for caveolae in cell migration

  2004cited by this paper
• Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer versus Small Cell Lung Cancer

  2004cited by this paper
• Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.

  2004cited by this paper
• Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays

  2004cited by this paper
• Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.

  2003cited by this paper
• Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells*

  2003cited by this paper
• Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking.

  2002cited by this paper
• Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.

  2002cited by this paper
• Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid

  2002cited by this paper
• Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.

  2002cited by this paper
• Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes.

  2002cited by this paper
• Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.

  2001cited by this paper
• Caveolin-1, a putative tumour suppressor gene.

  2001cited by this paper
• Hypermethylation of the caveolin‐1 gene promoter in prostate cancer

  2001cited by this paper
• Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

  2001cited by this paper
• Caveolin-1 Inhibits Epidermal Growth Factor-stimulated Lamellipod Extension and Cell Migration in Metastatic Mammary Adenocarcinoma Cells (MTLn3)

  2000cited by this paper
• Sequence and detailed organization of the human caveolin‐1 and ‐2 genes located near the D7S522 locus (7q31.1)

  1999cited by this paper
• Caveolin‐1 expression in Schwann cells

  1999cited by this paper
• ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motifs to high stoichiometry

  1999cited by this paper
• Reduction of caveolin 1 gene expression in lung carcinoma cell lines.

  1999cited by this paper
• Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer

  1998cited by this paper
• Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers

  1998cited by this paper
• Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo

  1998cited by this paper
• Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo

  1998cited by this paper
• Localization of a tumour‐suppressor gene associated with human oral cancer on 7q31.1

  1998cited by this paper
• Expression of caveolin-1 in human T cell leukemia cell lines.

  1998cited by this paper
• Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.

  1998cited by this paper
• Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach.

  1997cited by this paper
• Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas

  1997cited by this paper
• Cell-type and Tissue-specific Expression of Caveolin-2

  1997cited by this paper
• Two discrete regions of deletion at 7q in uterine leiomyomas

  1997cited by this paper
• Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells

  1996cited by this paper
• Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus.

  1996cited by this paper

• Therapeutic role of caveolin family in stem cell fate and development for management of chronic degenerative diseases: A scientometric study to an in-depth review.

  2025cites this paper
• Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review

  2025cites this paper
• Identification of novel biomarkers and prognostic model for neuroblastoma using Mendelian randomization and transcriptomic analysis

  2025cites this paper
• Cholesterol depletion induces mesenchymal properties in oral squamous cell carcinoma cell line.

  2024cites this paper
• Caveolin-2 palmitoylation turnover facilitates insulin receptor substrate-1-directed lipid metabolism by insulin receptor tyrosine kinase.

  2024cites this paper
• Caveolin-2 controls preadipocyte survival in the mitotic clonal expansion for adipogenesis.

  2024cites this paper
• Caveolin‐2 in association with nuclear lamina controls adipocyte hypertrophy

  2023cites this paper
• Differential expression of Cadherins switch and Caveolin-2 during stages of oral carcinogenesis

  2023cites this paper
• Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis

  2022cites this paper
• CAV2 Regulates Mir-4723/Wnt7A Signalling Axis through Endocytosis and Epithelial-Mesenchymal Transition to Promote Proliferation, Invasion, and Metastasis of Pancreatic Cancer Cells

  2022cites this paper
• MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase.

  2021cites this paper
• Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer

  2020cites this paper
• Alternative translation initiation of Caveolin-2 desensitizes insulin signaling through dephosphorylation of insulin receptor by PTP1B and causes insulin resistance.

  2018cites this paper
• CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

  2018cites this paper
• Insulin Receptor Isoforms in Physiology and Disease: An Updated View

  2017cites this paper
• Prediction of cancer drug sensitivity using high‐dimensional omic features

  2017cites this paper
• Caveolin proteins: a molecular insight into disease

  2016cites this paper
• Similarities in Gene Expression Profiles during In Vitro Aging of Primary Human Embryonic Lung and Foreskin Fibroblasts

  2015cites this paper
• Essential role of flotillin-1 palmitoylation in the intracellular localization and signaling function of IGF-1 receptor

  2015cites this paper
• Identification of Genes Related to Growth and Lipid Deposition from Transcriptome Profiles of Pig Muscle Tissue

  2015cites this paper
• CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer

  2015cites this paper
• MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.

  2015cites this paper
• Fatty acylated caveolin-2 is a substrate of insulin receptor tyrosine kinase for insulin receptor substrate-1-directed signaling activation.

  2015cites this paper
• Growth by Impairing Tumor Angiogenesis Host Deficiency in Caveolin-2 Inhibits Lung Carcinoma Tumor

  2014cites this paper
• Penalized Estimation Methods and Their Applications in Genomics and Beyond

  2014cites this paper
• Microenvironment and Immunology Host De fi ciency in Caveolin-2 Inhibits Lung Carcinoma Tumor Growth by Impairing Tumor Angiogenesis

  2014cites this paper
• Caveolin and cavin family members: dual roles in cancer.

  2014cites this paper
• Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes

  2014cites this paper
• Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis.

  2014cites this paper
• siRNA targeting of PRDX3 enhances cisplatin‑induced apoptosis in ovarian cancer cells through the suppression of the NF‑κB signaling pathway.

  2013cites this paper
• Intestinal Salmonella typhimurium Infection Leads to miR-29a Induced Caveolin 2 Regulation

  2013cites this paper
• Novel Insights into the Role of Caveolin-2 in Cell- and Tissue-Specific Signaling and Function

  2011cites this paper
• siRNA targeting of PRDX 3 enhances cisplatin ‐ induced apoptosis in ovarian cancer cells through the suppression of the NF ‐ κ B signaling pathway

  year unknowncites this paper